350 Episoder

  1. Episode 189: Biogen, Biogen, Biogen, with a dash of Omicron

    Publisert: 9.12.2021

  2. Episode 188: Carlos del Rio on Covid antivirals, an FDA conundrum, & the rise of Omicron

    Publisert: 2.12.2021

  3. Episode 187: Biogen’s scientific succession & Michael Osterholm on pandemic Thanksgiving

    Publisert: 18.11.2021

  4. Episode 186: Rebecca Robbins on Moderna v. NIH, plus psilocybin as a medicine

    Publisert: 11.11.2021

  5. Episode 185: John Maraganore on his next act, plus Moderna's setback & the drug pricing reform saga

    Publisert: 4.11.2021

  6. Episode 184: Vaccines for kids, inside Operation Warp Speed, & a big biotech resignation

    Publisert: 28.10.2021

  7. Episode 183: Greg Zuckerman on the vaccine race, plus Biogen's troubled launch

    Publisert: 21.10.2021

  8. Episode 182: The FDA star search, more booster debates, & the future of mRNA

    Publisert: 14.10.2021

  9. Episode 181: Brent Hodge on filming Shkreli, the next NIH director, and a looming FDA deadline

    Publisert: 7.10.2021

  10. Episode 180: Health equity 'tourism,' an $11B biopharma acquisition, & a bony Covid protest

    Publisert: 30.9.2021

  11. Episode 179: Scott Gottlieb on the next pandemic, another Covid winter, & Aduhelm's slow rollout

    Publisert: 23.9.2021

  12. Episode 178: Futuristic prosthetics, a treatment for ALS, & intrigue at the Holmes trial

    Publisert: 16.9.2021

  13. Episode 177: Bijan Salehizadeh on Covid tests, plus Verily's moment of truth

    Publisert: 9.9.2021

  14. Episode 176: Elizabeth Holmes on trial, FDA in disarray, & the quest for Covid antivirals

    Publisert: 2.9.2021

  15. Episode 175: Dorit Reiss on vaccine mandates, plus biotech's messy summer

    Publisert: 26.8.2021

  16. Episode 174: Biotech's trust issues, overwhelmed health workers, & the nuances of insider trading

    Publisert: 19.8.2021

  17. Episode 173: Biden's drug pricing plan, Wall Street's Alzheimer's fixation, & daily 5 a.m. alarms

    Publisert: 12.8.2021

  18. Episode 172: The mRNA gold rush, Delta's alarming rise, & the next treatment for Alzheimer's

    Publisert: 5.8.2021

  19. Episode 171: The quest for a Covid pill, a microbiome gut-check, & CRISPR on the big screen

    Publisert: 29.7.2021

  20. Episode 170: Céline Gounder on breakthrough infections, plus the power of lobbying

    Publisert: 22.7.2021

9 / 18

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Visit the podcast's native language site